Showing results (221-230 of 427) with videos related to

Sort By:
Pageof 43
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Endocrine therapy with or without inhibition of epidermal growth factor receptor and human epidermal growth factor receptor 2: a randomized, double-blind, placebo-controlled phase III trial of fulvestrant with or without lapatinib for postmenopausal women with hormone receptor-positive advanced breast cancer-CALGB 40302 (Alliance)Harold J Burstein, Constance T Cirrincione, William T Barry, et al.
Cancer|November 21, 2012
Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancerSusan M Domchek, Komal Jhaveri, Sujata Patil, et al.
Breast Cancer Research and Treatment|August 3, 2011
The impact of obesity on receipt of adjuvant chemotherapy for breast cancer in the National Comprehensive Cancer Network (NCCN) centersA M Brewster, C Etzel, R Zhou, et al.
Cancer Investigation|October 6, 2005
Phosphorylated/activated HER2 as a marker of clinical resistance to single agent taxane chemotherapy for metastatic breast cancerShanu Modi, Michael P DiGiovanna, Zhao Lu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 31, 2011
Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancerPatrick G Morris, Clifford A Hudis, Dilip Giri, et al.
Breast Cancer Research and Treatment|April 2, 2017
Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance)Jeanne S Mandelblatt, Ling Cai, George Luta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatmentsChau T Dang, Andrew J Dannenberg, Kotha Subbaramaiah, et al.
Seminars in Oncology|February 1, 1996
Sequential adjuvant therapy: the Memorial Sloan-Kettering Cancer Center experienceC Hudis, A Seidman, G Raptis, et al.
Clinical Breast Cancer|July 7, 2011
Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancerAyca Gucalp, Joseph A Sparano, James Caravelli, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|May 13, 2016
Copper-64 trastuzumab PET imaging: a reproducibility studyJorge A Carrasquillo, Patrick G Morris, John L Humm, et al.
Pageof 43